Gastrointestinal Stents Market Size, Share & Trends Analysis By Type (Biliary Stents, Duodenal Stents), By Application (Biliary Disease, Stomach Cancer), By Material, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Gastrointestinal Stents Market Size, Share & Trends Analysis By Type (Biliary Stents, Duodenal Stents), By Application (Biliary Disease, Stomach Cancer), By Material, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Gastrointestinal Stents Market Growth & Trends

The global gastrointestinal stents market size is expected to reach USD 611.4 million by 2030, registering a CAGR of 5.2% during the forecast period, according to a new report by Grand View Research, Inc. Increasing burden of gastrointestinal diseases including biliary diseases, esophageal cancer, and colorectal cancer are anticipated to boost the usage of GI stents across the globe.

Individuals above 60 years of age form the key target population for these products, as they are at a high risk of developing gastrointestinal and stomach-related diseases. Thus, aging demographics of most of the economies around the globe is a prime factor driving the growth of the sector. Moreover, reimbursement coverage provided by the Center for Medicare & Medicaid Services (CMS) and various private payers is spurring the adoption of GI stents.

Gastrointestinal Stents Market Report Highlights

• The gastrointestinal stents market study suggests that biliary stent dominated the overall sector in 2023. Incidences of biliary diseases such as bile duct cancer, gallstone disease and primary biliary cholangitis are on the rise globally, which would drive the growth of biliary stents sector positively.
• Duodenal stents are projected to emerge as the fastest-growing segment during the forecast period. Attributed to the rising gastrointestinal disorders such as tumors, strictures, and other pathologies.
• North America occupied the largest revenue share in 2023, due to the high rate of diagnosing new cases of gastrointestinal diseases and constantly rising awareness regarding commercial availability of effective treatments.
• In addition, increasing incidences of irritable bowel syndrome, colorectal cancer and pancreatic cancer are a few high impact-rendering drivers for the market.
• Asia Pacific is expected to witness a significant growth during the forecast period. The presence of countries such as Japan, China and India with constantly increasing patient population is a key factor anticipated to fuel the market growth in the region.

Please note The report will be delivered in 2-3 business days upon order notification.